“…The scale has been documented to be a reliable and valid tool for assessing psychosocial risk in the general child population, as well as in specific populations (e.g., pediatric population with epilepsy; Blucker et al, 2014; Erdogan & Ozturk, 2011; Liu, Burgess, et al, 2020; Wagner et al, 2015). Up to now, the psychometric properties of the PSC-17 have been established in diverse populations, including but not limited to the United States (Liu, Burgess et al, 2020), India (Chaurasiya et al, 2019), China (Liu et al, 2022), and Turkey (Erdogan & Ozturk, 2011). More importantly, the free nature of the PSC-17 does not bring a financial burden on institutions such as the government, schools, and hospitals for screening children’s psychosocial risk.…”